Comparison of blood dynamics of anticancer drugs (cisplatin, mitomycin C, epirubicin) in treatment groups of hepatic arterial infusion, hepatic arterial infusion with lipiodol and transcatheter arterial chemoembolization with lipiodol plus gelatin sponge particles in a swine model

Hepatology Research

Volumn 42, Issue 12, 2012, Pages 1227-1235

  Ikoma, Akira ^a   Kawai, Nobuyuki ^a   Sato, Morio ^a   Minamiguchi, Hiroki ^a   Nakai, Motoki ^a   Nakata, Kouhei ^a   Tanaka, Takami ^a   Sonomura, Tetsuo ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatic arterial infusion; Lipiodol; Liver damage; Transcatheter arterial chemoembolization

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CISPLATIN; CREATININE; DEXTRO AMINO ACID AMINOTRANSFERASE; EPIRUBICIN; FARMORBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; LACTATE DEHYDROGENASE; MITOMYCIN; MITOMYCIN C; POTASSIUM; SODIUM; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD; CHEMOEMBOLIZATION; CREATININE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; LIVER NECROSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SWINE; UREA NITROGEN BLOOD LEVEL;

EID: 84870278558     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01040.x     Document Type: Article

References (23)

1. Nakakuma K, Tashiro S, Hiraoka T etal. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983; 52: 2193-200.
2. Ohishi H, Uchida H, Yoshimura H etal. Hepatocellular carcinoma detected by iodized oil. Radiology 1985; 154: 25-9.
3. Sumie S, Yamashita F, Ando E etal. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. Am J Roentgenol 2003; 181: 1327-34.
4. Seki H, Ozaki T, Shiina M. Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit. Am J Roentgenol 2008; 190: 111-20.
5. Takayasu K, Arii S, Ikai I etal. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. Am J Roentgenol 2010; 194: 830-37.
6. Kanematsu T, Inokuchi K, Sugimachi K etal. Selective effects of lipiodolized antitumor agents. J Surg Oncol 1984; 25: 218-26.
7. Llovet JM, Real MI, Montana X etal. Arterial embolization or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002; 359: 1734-9.
8. Lo CM, Ngan H, Tso WK etal. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-71.
9. Takayasu K, Arii S, Ikai I etal. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131: 461-9.
10. Gomes AS, Rosove MH, Rosen PJ etal. Triple-Drug transcatheter arterial chemoembolization in unresectable hepatocelular carcinoma: assessment of survival in 124 consecutive patients. Am J Roentgenol 2009; 193: 1665-71.
11. Brown DB, Pilgram TK, Darcy MD etal. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 2005; 16: 1661-6.
12. Solomon B, Soulen MC, Baum RA, Haskal ZJ, Shlansky-Goldberg RD, Cope C. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 1999; 10: 793-8.
13. Sahara S, Kawai N, Sato M etal. Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma. Jpn J Radiol 2010; 28: 362-8.
14. Sakamato I, Aso N, Nagaoki K etal. Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 1998; 18: 605-19.
15. Nagata M, Matsuo Y, Hidaka M etal. Effect of acute hepatic failure on epirubicin pharmacokinetics after intrahepatic arterial injection in rats. Biol Pharm Bull 2008; 31: 493-96.
16. Takahashi K, Ebihara K, Honda Y etal. Antitumor activity of cis-dichlorodiammineplatinum (II) and its effect on cell cycle progression. Jpn J Cancer Chemother 1982; 9: 624-31.
17. Sugiura K. Studies in a tumor spectrum VIII. The effect of mitomycin C on the growth of a variety of a mouse, rat, and hamster tumors. Cancer Res 1959; 19: 438-45.
18. Bonadonna G, Gianni L, Santoro A etal. Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors. Ann Oncol 1993; 4: 359-69.
19. Schwartz HS. Pharmacology of mitomycin C: III. In vitro metabolism by rat liver. J Pharmacol Exp Ther 1962; 136: 250-8.
20. Sasaki Y, Kurihara M, Izumi T etal. Experimental study on abdominal arterial infusion of anti-cancer agents. Jpn J Cancer Chemother 1983; 10: 2023-9.
21. Sato M, Yamada R, Uchida B, Hedgepeth P, Rosch J. Effects of hepatic artery embolization with lipiodol and gelatin sponge particles on normal swine liver. Cardiovasc Intervent Radiol 1993; 16: 348-54.
22. Sahara S, Tanihata H, Sato M etal. Effect of Hepatic Artery Chemoembolization Using Cisplatin-lipiodol Suspension with Gelatin Sponge Particles on Swine Liver. J Vasc Interv Radiol 2009; 20: 1359-64.
23. Masuda M. Evaluation of basic and clinical study on effect of anticancer drugs of lipiodol in chemoembolization on liver tissue. J Wakayama Med Soc 2002; 53: 185-92. (In Japanese.)